Literature DB >> 28822620

Medications and Adverse Voice Effects.

Kátia Nemr1, Ariana Di Carlos Silva2, Danilo de Albuquerque Rodrigues2, Marcia Simões Zenari2.   

Abstract

OBJECTIVES: To identify the medications used by patients with dysphonia, describe the voice symptoms reported on initial speech-language pathology (SLP) examination, evaluate the possible direct and indirect effects of medications on voice production, and determine the association between direct and indirect adverse voice effects and self-reported voice symptoms, hydration and smoking habits, comorbidities, vocal assessment, and type and degree of dysphonia. STUDY
DESIGN: This is a retrospective cross-sectional study.
METHODS: Fifty-five patients were evaluated and the vocal signs and symptoms indicated in the Dysphonia Risk Protocol were considered, as well as data on hydration, smoking and medication use. We analyzed the associations between type of side effect and self-reported vocal signs/symptoms, hydration, smoking, comorbidities, type of dysphonia, and auditory-perceptual and acoustic parameters.
RESULTS: Sixty percent were women, the mean age was 51.8 years, 29 symptoms were reported on the screening, and 73 active ingredients were identified with 8.2% directly and 91.8% indirectly affecting vocal function. There were associations between the use of drugs with direct adverse voice effects, self-reported symptoms, general degree of vocal deviation, and pitch deviation.
CONCLUSIONS: The symptoms of dry throat and shortness of breath were associated with the direct vocal side effect of the medicine, as well as the general degree of vocal deviation and the greater pitch deviation. Shortness of breath when speaking was also associated with the greatest degree of vocal deviation.
Copyright © 2018 The Voice Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medications; Speech-language pathology; Voice; Voice disorders; Voice symptoms

Mesh:

Year:  2017        PMID: 28822620     DOI: 10.1016/j.jvoice.2017.07.009

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  2 in total

1.  Voice deviation, dysphonia risk screening and quality of life in individuals with various laryngeal diagnoses.

Authors:  Katia Nemr; Ariane Cota; Domingos Tsuji; Marcia Simões-Zenari
Journal:  Clinics (Sao Paulo)       Date:  2018-03-12       Impact factor: 2.365

2.  COVID-19 and the teacher's voice: self-perception and contributions of speech therapy to voice and communication during the pandemic.

Authors:  Katia Nemr; Marcia Simões-Zenari; Vanessa Cássia de Almeida; Glauciene Amaral Martins; Isabele Tiemi Saito
Journal:  Clinics (Sao Paulo)       Date:  2021-03-26       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.